Okt 30, 2012 | Allgemein, company news @en, DE, general conditions, market knowledge
More than three quarters of hospitals in Germany have difficulty filling their managerial positions. This is at its worst in small private clinics with up to 250 beds. These results from the study „Klinikmanagement 2012“ for the consulting firm Rochus...
Okt 27, 2012 | Allgemein, company news @en, DE
The French pharmaceutical company Sanofi is under increasing competition from generic manufacturers as profits dropped in the 3rd quarter of 2012. Between July and September, profits of Sanofi fell by almost a quarter: net income fell from July through September by...
Okt 27, 2012 | Allgemein, company news @en, DE
This week, DocMorris – belonging to Swiss wholesalers Zur Rose – has announced its bonus model. Customers will receive a discount in the future, of only one Euro for each prescription. Further, customers can get up to a 15 Euro bonus if they participate in...
Okt 26, 2012 | Allgemein, company news @en, DE
The biotech company Qiagen and Bayer HealthCare will cooperate in the future in cancer diagnostics. Together, diagnostics for new drugs will be developed and marketed by Bayer. Personalised medicine, ie the targeted treatment of patients according to their genetic...
Okt 26, 2012 | Allgemein, company news @en, DE
The American pharmaceutical company Eli Lilly and Co has announced that its profit rose in the third quarter. Net income amounted to $1.33 billion. Revenue, however, declined significantly, due largely to the expiry of patents for the drug Zyprexa. Sales declined 11...
Okt 26, 2012 | Allgemein, company news @en, DE
The Swiss pharmaceutical company Novartis has announced an improved third quarter. The net profit was $2.48 billion on the previous year. The turnover of the Basel-based pharmaceutical company decreased by seven percent to $13.81 billion. Excluding exchange rate...